In a Japanese case series, two in five primary breast cancers in patients with BRCA1/2 mutation were only detectable on MRI in a 48-month breast cancer surveillance program including biannual ultrasonography, annual mammography, and MRI (31). This evidence concerns the gene BRCA1 and breast cancer.